Invention Grant
- Patent Title: Use of NF-κB inhibition in combination therapy for cancer
-
Application No.: US11535720Application Date: 2006-09-27
-
Publication No.: US07700545B2Publication Date: 2010-04-20
- Inventor: Albert S. Baldwin , James C. Cusack , Marty W. Mayo , Cun-Yu Wang
- Applicant: Albert S. Baldwin , James C. Cusack , Marty W. Mayo , Cun-Yu Wang
- Applicant Address: US NC Chapel Hill
- Assignee: The University of North Carolina at Chapel Hill
- Current Assignee: The University of North Carolina at Chapel Hill
- Current Assignee Address: US NC Chapel Hill
- Agency: Myers Bigel Sibley & Sajovec, P.A.
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The use of NF-κB inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
Public/Granted literature
- US20070110828A1 Use of NF-kB Inhibition in Combination Therapy for Cancer Public/Granted day:2007-05-17
Information query
IPC分类:
